ThermoGenesis Corp. (KOOL: Quote) reported a fourth-quarter net loss of $0.7 million or $0.04 per share, narrower than the net loss of $1.2 million or $0.07 per share in the comparable quarter last year.
Net revenues for the latest quarter declined to $4.5 million from $5.4 million last year.
The company attributed the decline in revenues to decreased sales of BioArchive System devices, reflecting the continuing softness in worldwide capital equipment purchase activity.
ThermoGenesis is a supplier of enabling technologies for the processing, storage and administration of cell therapies.
Click here to receive FREE breaking news email alerts for THERMOGENESIS CORP and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org